Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics

IMPORTANCE: Limited evidence is available on the comparative effectiveness of empagliflozin vs alternative second-line glucose-lowering agents in patients with type 2 diabetes (T2D) receiving routine care who have a broad spectrum of cardiorenal risk. OBJECTIVE: To evaluate the association of empagl...

Descripción completa

Detalles Bibliográficos
Autores principales: Htoo, Phyo T., Tesfaye, Helen, Schneeweiss, Sebastian, Wexler, Deborah J., Everett, Brendan M., Glynn, Robert J., Kim, Seoyoung C., Najafzadeh, Mehdi, Koeneman, Lisette, Farsani, Soulmaz Fazeli, Déruaz-Luyet, Anouk, Paik, Julie M., Patorno, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585433/
https://www.ncbi.nlm.nih.gov/pubmed/36264574
http://dx.doi.org/10.1001/jamanetworkopen.2022.37606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585433/
https://www.ncbi.nlm.nih.gov/pubmed/36264574
http://dx.doi.org/10.1001/jamanetworkopen.2022.37606

Ejemplares similares